Icon

DAKLINZA - (30MG, 60MG, 90MG)

DACLATASVIR DIHYDROCHLORIDE None
30MG, 60MG, 90MG
Less Than $1000 mn
None None
None None
None None
DAKLINZA is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection.
Yes
DAKLINZA Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.